Valeant Pharmaceuticals Appoints President of Valeant Pharmaceuticals International
ALISO VIEJO, Calif., March 19 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals (NYSE: VRX ) today announced that it has appointed Dr. Bhaskar Chaudhuri to the position of President, Valeant Pharmaceuticals International, effective March 10, 2009. In this role, Dr. Chaudhuri will assume respons...Sanofi-Aventis Recognized for Workplace Efforts to Prevent Cancer
...ncology Nursing Society, OSI Pharmaceuticals, Pfizer, PhRMA, PPD, Quintiles Transnational, SAS Institute, The University of North Dakota, US Oncology, valeant Pharmaceuticals, Vanderbilt-Ingram Cancer Center, Virtua Health and The Wistar Institute. About the CEO Roundtable on Cancer The CEO Round...Valeant Pharmaceuticals Reports Second Quarter Financial Results
...SO VIEJO, Calif., Aug. 4 /PRNewswire-FirstCall/ -- valeant Pharmaceuticals International (NYSE: VRX ) today... Conference Call and Webcast Information: valeant will host a conference call and a live Internet we...ww.valeant.com . About Valeant: valeant Pharmaceuticals International (NYSE: VRX ) is a ...Valeant to Acquire Tecnofarma, A Mexican Generic Company
...O VIEJO, Calif., July 29 /PRNewswire-FirstCall/ -- valeant Pharmaceuticals International (NYSE: VRX ) annou...ment and private label markets - two segments that valeant Mexico does not currently serve in any material wa...60,000 sq. ft. manufacturing plant that will allow valeant Latin America to reduce its dependence upon third ...Valeant Pharmaceuticals to Announce 2009 Second Quarter Results on August 4, 2009
...ations section at www.valeant.com. About valeant valeant Pharmaceuticals International (NYSE: VRX ) is a m...neurology and dermatology. More information about valeant can be found at www.valeant.com . ...AMN Healthcare Names New Chief Financial Officer
... most recent position was that as CFO and Executive Vice President (EVP) at valeant Pharmaceuticals International, a specialty pharmaceutical company. Bailey joined valeant in 2002 and was instrumental in restructuring the company to focus on its c...New Report Just Published: World Hepatitis C Virus And Therapeutics Market Report
...rporation, Tibotec Pharmaceuticals Ltd., Tripep AB, Toray Industries, Inc., valeant Pharmaceuticals International, and Vertex Pharmaceuticals, Inc. Market data...7 Tripep AB (Sweden) II-77 Toray Industries, Inc. (Japan) II-77 valeant Pharmaceuticals International (USA) II-78 Vertex Pharmaceuticals, Inc. ...Richard A. Meier Appointed to STAAR Surgical Board of Directors
...tive vice president and chief financial officer of valeant Pharmaceuticals International (formerly ICN Pharmaceuticals, Inc.). Before joining valeant Pharmaceuticals, Mr. Meier was a senior vice presi...& Co. Inc. in New York from 1996 until joining valeant Pharmaceuticals in 1998. Prior to Mr. Meier's expe...Acanya(TM) Gel, a New Treatment for Moderate to Severe Acne, Launched by Coria Laboratories
... Expanded Dermatology Division of valeant Pharmaceuticals Introduces Fixed Combination Acne ...tories, the newly expanded dermatology division of valeant Pharmaceuticals International (NYSE: VRX ), ann...s, now a part of Coria Laboratories, a division of valeant Pharmaceuticals International. Acanya Gel is prot...Valeant Pharmaceuticals Announces Publication of Retigabine Phase 2 Study Data in Neurology
... experiencing a seizure in their lifetime. About valeant valeant Pharmaceuticals International (NYSE:VRX) is a glob...us disease and dermatology. More information about valeant can be found at www.valeant.com. Contact ...DFB Sells Coria Labs to Valeant Pharmaceuticals
FORT WORTH, Texas, Sept. 17 /PRNewswire/ -- H. Paul Dorman, Chairman and Chief Executive Officer of Fort Worth-based DFB Pharmaceuticals, Inc., today announced that DFB has signed a definitive agreement to sell its dermatology division Coria Laboratories, Ltd. to Valeant Pharmaceuticals Intern...Valeant Pharmaceuticals Reports Encouraging Final Results With Taribavirin Phase IIb Study
...SO VIEJO, Calif., June 1 /PRNewswire-FirstCall/ -- valeant Pharmaceuticals International (NYSE: VRX ) today...in may be as effective as weight based ribavirin. valeant plans to present the full final data at the Americ...000 IU/mL and 82.1 kg mean weight. About valeant ...Valeant Pharmaceuticals Completes Acquisition of Dow Pharmaceutical Sciences, Inc.
...eutical and biotechnology companies. About valeant valeant Pharmaceuticals International (NYSE: VRX ) is a ...neurology and dermatology. More information about valeant can be found at http://www.valeant.com . ...Valeant to Acquire Dow Pharmaceutical Sciences, Inc. for $285 Million
...erapies. Under the terms of the agreement, valeant will pay Dow $285 million, subject to certain clos...ccounts, making the net amount paid $277 million. valeant will make the first payment of $250 million upon c...ich will be subject to indemnification claims from valeant for a period of eighteen months following closing....Cytopia Strengthens Scientific Team With US-Based Drug Development Specialist
...r, to provide scientific leadership and guidance. He has held global leadership roles at Glaxo Wellcome and Burroughs Wellcome and in recent years, at valeant Pharmaceuticals International and Anadys Pharmaceuticals, Inc, a company he co-founded. Holding a Ph.D. in Microbiology and Immunology, Dr. Averett ...ABT is the Only Source for Kelo-cote(R) Advanced Formula Scar Gel
...onger available under the Dermatix label. Doctors and customers should not be misled by competitors' claims they offer the same product. Specifically, valeant Pharmaceutical's claim that Dermatix and Dermatix Ultra contain the same formula or an improvement of Kelo-cote(R) advanced formula scar gel is FALSE....Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes
... INC (Tokyo SE: 3402) TOYOBO CO (Tokyo SE: 3101) valeant PHARMACEUTICALS INTL (NYSE: VRX ) HealthShares(...Tokyo SE: 4518) TRANSGENE (Euronext, Paris: TNG) valeant PHARMACEUTICALS INTL (NYSE: VRX ) VERTEX PHARMAC...X ) SUCAMPO PHARMACEUTICALS INC (NASDAQ: SCMP ) valeant PHARMACEUTICALS INTL (NYSE: VRX ) XENOPORT INC (...Senetek PLC Reports First Quarter 2008 Financial Results
...e previously announced grant of a paid up license for Kinetin and Zeatin to valeant Pharmaceuticals Inc. Net loss for the quarter ended March 31, 2008 totale...e previously announced grant of a paid up license for Kinetin and Zeatin to valeant Pharmaceuticals Inc. and $1,320,000 from settlement of claims against a pro...Senetek PLC Announces Appointments of Key Personnel
...s for Glaxo Pharmaceuticals, Inc. In 1997 he became Vice President and General Manager of North American Operations for ICN Pharmaceuticals, Inc. (now valeant Pharmaceuticals). He then went on to become President and CEO of Obagi Medical Products, a specialty pharmaceutical company focused in aesthetic medic...